Our first site, Newcastle upon Tyne Hospitals NHS Foundation Trust, led by Professor Helen Reeves, opened on 1 November 2019.

We now have 9 sites open to recruitment with Cambridge soon to follow:

NHS Greater Glasgow & Clyde, opened October 2020 & led by Professor Jeff Evans.

King's College Hospital, London, opened November 2020 & led by Dr Debashis Sarkar.

Royal Free London NHS Foundation Trust, opened November 2020 & led by Professor Tim Meyer.

Imperial College Healthcare NHS Trust, opened March 2021 & led by Dr Rohini Sharma.

University Hospital Southampton NHS Trust, opened October 2021 & led by Professor Salim Khakoo.

The Clatterbridge Cancer Centre, Liverpool, opened November 2021 & led by Professor Daniel Palmer.

University Hospitals Birmingham NHS Foundation Trust, opened November 2021 & led by Dr Shish Shetty.

Cambridge University Hospitals NHS Foundation Trust, led by Dr Matt Hoare.

if you are a Clinical site with an interest in liver resections for HCC, or administration of locoregiobal or medical therapies, and are interested in taking part, please contact your local CPMS coordinator.

There is an urgent need to develop new approaches for HCC therapy. To ad‌dress this we have assembled an international and multidisciplinary team of investigators who will combine their resources and cross-disciplinary expertise to develop research platforms and train/prepare young researchers to accelerate the rate at which the wider research community can generate new knowledge in the biology of liver cancer.